Quzyttir Injection

Generic name:cetirizine hydrochloride
Dosage form: injection
Drug class:Antihistamines

Medically reviewed by Drugs.com. Last updated on Mar 22, 2022.

Indications and Usage for Quzyttir Injection

QUZYTTIR™ is indicated for the treatment of acute urticaria in adults and children 6 months of age and older.

Limitations of use:

QUZYTTIR™ is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.

Quzyttir Injection Dosage and Administration

QUZYTTIR is a single use injectable product for intravenous administration only. The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria. Administer QUZYTTIR as an intravenous push over a period of 1 to 2 minutes. QUZYTTIR is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function [see Pediatric Use (8.4)].

Adults and adolescents 12 years of age and older

The recommended dosage is 10 mg administered by intravenous injection.

Children 6 to 11 years of age

The recommended dosage is 5 mg or 10 mg depending on symptom severity administered by intravenous injection.

Children 6 months to 5 years of age

The recommended dosage is 2.5 mg administered by intravenous injection.

Dosage Forms and Strengths

QUZYTTIR is a sterile, clear, colorless, non-pyrogenic, isotonic aqueous solution of cetirizine hydrochloride for intravenous injection; supplied in 2 mL size amber glass vials for single use. Each 2 mL size amber glass vial contains 1 mL drug solution with 10 mg cetirizine hydrochloride (equivalent to 8.42 mg of cetirizine).

Contraindications

The use of QUZYTTIR is contraindicated in patients with a known hypersensitivity to cetirizine hydrochlori...